Human rheumatoid arthritis tissue production of IL-17A drives matrix and cartilage degradation: synergy with tumour necrosis factor-α, Oncostatin M and response to biologic therapies
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1478-6354
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Human rheumatoid arthritis tissue production of IL-17A drives matrix and cartilage degradation: synergy with tumour necrosis factor-α, Oncostatin M and response to biologic therapies ; volume:11 ; number:4 ; day:23 ; month:7 ; year:2009 ; pages:1-12 ; date:8.2009
Arthritis Research & Therapy ; 11, Heft 4 (23.7.2009), 1-12, 8.2009
- Urheber
-
Moran, Ellen M.
- Beteiligte Personen und Organisationen
-
Mullan, Ronan
McCormick, Jennifer
Connolly, Mary
Sullivan, Owen
FitzGerald, Oliver
Bresnihan, Barry
Veale, Douglas J.
Fearon, Ursula
SpringerLink (Online service)
- DOI
-
10.1186/ar2772
- URN
-
urn:nbn:de:1111-2016050313216
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:49 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Moran, Ellen M.
- Mullan, Ronan
- McCormick, Jennifer
- Connolly, Mary
- Sullivan, Owen
- FitzGerald, Oliver
- Bresnihan, Barry
- Veale, Douglas J.
- Fearon, Ursula
- SpringerLink (Online service)
Ähnliche Objekte (12)
Novel anti-HER2 monoclonal antibodies: synergy and antagonism with tumor necrosis factor-α
Evaluating the efficacy of sequential biologic therapies for rheumatoid arthritis patients with an inadequate response to tumor necrosis factor-α inhibitors
Tumor necrosis factor-α and muscle wasting: a cellular perspective
Commercially Available Antibodies to Human Tumour Necrosis Factor-α Tested for Cross-Reactivity with Ovine and Bovine Tumour Necrosis Factor-α using Flow Cytometric Assays
Natural Inhibitors of Tumour Necrosis Factor-α Production, Secretion and Function
Tumor necrosis factor-α links heat and inflammation with Fabry pain
Microinjury-Induced Tumor Necrosis Factor-α Surge Stimulates Hair Regeneration in Mice
A role for tumor necrosis factor-α in ischemia and ischemic preconditioning
Tumour necrosis factor-α production in fibrosing alveolitis is macrophage subset specific
Novel peptide inhibitor of human tumor necrosis factor-α has antiarthritic activity
CD14 Counterregulates Lipopolysacharide-Induced Tumor Necrosis Factor-α Production in a Macrophage Subset
Peripheral nerve injury sensitizes neonatal dorsal horn neurons to tumor necrosis factor-α
Novel anti-HER2 monoclonal antibodies: synergy and antagonism with tumor necrosis factor-α
Evaluating the efficacy of sequential biologic therapies for rheumatoid arthritis patients with an inadequate response to tumor necrosis factor-α inhibitors
Tumor necrosis factor-α and muscle wasting: a cellular perspective
Commercially Available Antibodies to Human Tumour Necrosis Factor-α Tested for Cross-Reactivity with Ovine and Bovine Tumour Necrosis Factor-α using Flow Cytometric Assays
Natural Inhibitors of Tumour Necrosis Factor-α Production, Secretion and Function
Tumor necrosis factor-α links heat and inflammation with Fabry pain
Microinjury-Induced Tumor Necrosis Factor-α Surge Stimulates Hair Regeneration in Mice
A role for tumor necrosis factor-α in ischemia and ischemic preconditioning
Tumour necrosis factor-α production in fibrosing alveolitis is macrophage subset specific
Novel peptide inhibitor of human tumor necrosis factor-α has antiarthritic activity
CD14 Counterregulates Lipopolysacharide-Induced Tumor Necrosis Factor-α Production in a Macrophage Subset
Peripheral nerve injury sensitizes neonatal dorsal horn neurons to tumor necrosis factor-α
Novel anti-HER2 monoclonal antibodies: synergy and antagonism with tumor necrosis factor-α
Evaluating the efficacy of sequential biologic therapies for rheumatoid arthritis patients with an inadequate response to tumor necrosis factor-α inhibitors
Tumor necrosis factor-α and muscle wasting: a cellular perspective
Commercially Available Antibodies to Human Tumour Necrosis Factor-α Tested for Cross-Reactivity with Ovine and Bovine Tumour Necrosis Factor-α using Flow Cytometric Assays
Natural Inhibitors of Tumour Necrosis Factor-α Production, Secretion and Function
Tumor necrosis factor-α links heat and inflammation with Fabry pain
Microinjury-Induced Tumor Necrosis Factor-α Surge Stimulates Hair Regeneration in Mice
A role for tumor necrosis factor-α in ischemia and ischemic preconditioning
Tumour necrosis factor-α production in fibrosing alveolitis is macrophage subset specific
Novel peptide inhibitor of human tumor necrosis factor-α has antiarthritic activity
CD14 Counterregulates Lipopolysacharide-Induced Tumor Necrosis Factor-α Production in a Macrophage Subset